Literature DB >> 12446971

Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation.

Marina P Sánchez1, Isabel Gonzalo, Jesús Avila, Justo García De Yébenes.   

Abstract

Autosomal recessive-juvenile parkinsonism (AR-JP) is one of the most common forms of familial Parkinson's disease (PD) and is related to mutations in the Park-2 gene, encoding for a protein ligase of ubiquitin, parkin. Different mutations located along the parkin gene have been observed in different AR-JP affected families, possibly interfering with the normal function of parkin and the proteasome system. Two cases of patients with AR-JP have been recently described presenting different homo- and heterozygous parkin mutations and limited tau pathology. We report here the case of a patient with clinical and pathological findings compatible with progressive supranuclear palsy (PSP), carrier of a single, heterozygous mutation of the parkin gene, and homozygous for the H1/H1 haplotype in the tau gene. Abnormal tau hyperphosphorylation has been observed in our patient brain samples, suggesting that a partial deficit of parkin, a protein with ubiquitin-ligase function, may trigger tau pathology in individuals with molecular genetic risk factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446971     DOI: 10.3233/jad-2002-4506

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  β-amyloid triggers ALS-associated TDP-43 pathology in AD models.

Authors:  Alexander M Herman; Preeti J Khandelwal; Brenna B Stanczyk; G William Rebeck; Charbel E-H Moussa
Journal:  Brain Res       Date:  2011-03-02       Impact factor: 3.252

2.  P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway.

Authors:  Holly C Hunsberger; Carolyn C Rudy; Seth R Batten; Greg A Gerhardt; Miranda N Reed
Journal:  J Neurochem       Date:  2014-10-31       Impact factor: 5.372

Review 3.  Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy.

Authors:  Lingling Jiao; Xixun Du; Yong Li; Qian Jiao; Hong Jiang
Journal:  Mol Biol Rep       Date:  2022-07-06       Impact factor: 2.316

4.  Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Authors:  Charbel E-H Moussa
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

5.  Genetic neuropathology of Parkinson's disease.

Authors:  Mark R Cookson; John Hardy; Patrick A Lewis
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 6.  Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.

Authors:  Pawel Tacik; Monica Sanchez-Contreras; Rosa Rademakers; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Neurodegener Dis       Date:  2015-11-10       Impact factor: 2.977

Review 7.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

8.  The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.

Authors:  Preeti J Khandelwal; Charbel E-H Moussa
Journal:  Front Psychiatry       Date:  2010-06-03       Impact factor: 4.157

9.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

Review 10.  Parkin Regulation and Neurodegenerative Disorders.

Authors:  Cheng-Wu Zhang; Liting Hang; Tso-Pang Yao; Kah-Leong Lim
Journal:  Front Aging Neurosci       Date:  2016-01-12       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.